NYSE - Delayed Quote USD
STERIS plc (STE)
At close: November 22 at 4:00 PM EST
After hours: November 22 at 6:01 PM EST
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
5,325,525.00
5,138,701.00
4,536,266.00
4,223,403.00
3,107,519.00
Cost of Revenue
3,031,376.00
2,920,541.00
2,555,540.00
2,340,396.00
1,764,419.00
Gross Profit
2,294,149.00
2,218,160.00
1,980,726.00
1,883,007.00
1,343,100.00
Operating Expense
1,387,603.00
1,355,997.00
1,189,140.00
1,405,144.00
797,646.00
Operating Income
906,546.00
862,163.00
791,586.00
477,863.00
545,454.00
Net Non Operating Interest Income Expense
-114,244.00
-133,308.00
-110,835.00
-83,206.00
-30,835.00
Other Income Expense
-41,974.00
-26,045.00
-485.00
-27,854.00
2,914.00
Pretax Income
750,328.00
702,810.00
680,266.00
366,803.00
517,533.00
Tax Provision
157,091.00
149,530.00
124,069.00
82,344.00
120,663.00
Net Income Common Stockholders
434,801.00
378,239.00
107,030.00
243,888.00
397,400.00
Diluted NI Available to Com Stockholders
434,801.00
378,239.00
107,030.00
243,888.00
397,400.00
Basic EPS
4.40
3.83
1.07
2.50
4.66
Diluted EPS
4.38
3.81
1.07
2.48
4.63
Basic Average Shares
98,798.00
98,787.00
99,706.00
97,535.00
85,203.00
Diluted Average Shares
99,342.50
99,359.00
100,246.00
98,326.00
85,898.00
Total Operating Income as Reported
852,001.00
836,118.00
791,101.00
477,815.00
548,368.00
Total Expenses
4,418,979.00
4,276,538.00
3,744,680.00
3,745,540.00
2,562,065.00
Net Income from Continuing & Discontinued Operation
434,801.00
378,239.00
107,030.00
243,888.00
397,400.00
Normalized Income
624,567.19
571,937.42
557,810.73
285,514.06
395,165.40
Interest Income
10,864.00
11,043.00
--
6,284.00
6,345.00
Interest Expense
125,108.00
144,351.00
110,835.00
89,490.00
37,180.00
Net Interest Income
-114,244.00
-133,308.00
-110,835.00
-83,206.00
-30,835.00
EBIT
875,436.00
847,161.00
791,101.00
456,293.00
554,713.00
EBITDA
1,378,456.00
1,412,405.00
1,343,998.00
1,009,397.00
773,950.00
Reconciled Cost of Revenue
3,031,376.00
2,920,541.00
2,555,540.00
2,340,396.00
1,764,419.00
Reconciled Depreciation
503,020.00
565,244.00
552,897.00
553,104.00
219,237.00
Net Income from Continuing Operation Net Minority Interest
591,381.00
551,440.00
557,414.00
285,477.00
397,400.00
Total Unusual Items Excluding Goodwill
-41,974.00
-26,045.00
-485.00
-48.00
2,914.00
Total Unusual Items
-41,974.00
-26,045.00
-485.00
-48.00
2,914.00
Normalized EBITDA
1,420,430.00
1,438,450.00
1,344,483.00
1,009,445.00
771,036.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-8,787.81
-5,547.59
-88.27
-10.94
679.40
3/31/2021 - 6/1/1992
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SNN Smith & Nephew plc
25.31
+1.08%
PODD Insulet Corporation
262.93
+0.35%
ZBH Zimmer Biomet Holdings, Inc.
110.22
+1.68%
EW Edwards Lifesciences Corporation
70.48
+0.14%
BIO Bio-Rad Laboratories, Inc.
332.91
+2.25%
INSP Inspire Medical Systems, Inc.
188.73
+1.36%
SYK Stryker Corporation
384.85
-1.36%
CEVI.ST CellaVision AB (publ)
217.00
+1.17%
GMED Globus Medical, Inc.
84.72
-0.22%
LIVN LivaNova PLC
51.32
-0.74%